Patrocinado
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
Postado
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Pesquisar
Categorias
- National
- International
- Business
- Technology
- Health
- Educação
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Leia Mais
One killed, another injured in lightning strike in Taplejung
TAPLEJUNG: A man has died and another has been injured after being struck by lightning in...
Neena Gupta opens up about her FIRST husband
Neena Gupta reminisced about her early romances. Her first love was an IIT student, whom she...
Leaked audio implicates former Bangladeshi leader Hasina in deadly protest crackdown
DHAKA: Former Bangladeshi Prime Minister Sheikh Hasina directly ordered security forces to use...
Is Payal and Sangram headed for a divorce
Rumors of separation surround Payal Rohatgi and Sangram Singh after Payal resigned from Sangram's...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Portuguese
